Synonyms: RDC8
Anti-AA2AR / Adenosine A2aR (3F6-9G5) is a monoclonal antibody targeting A2A adenosine receptor. It may be an attractive target for research studies or treatments of insomnia, pain, depression, and Parkinson's disease. MW :146.66 KD.
| Featured Inhibitors | Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933 |
|---|
| Name | Citation | Adenosine Receptor | Adenosine receptor | Adenosine A1 receptor | Others |
|---|---|---|---|---|---|
| Taminadenant | 0 | ||||
| DPCPX | 1 | ||||
| SCH-442416 | 0 | ||||
| Preladenant | 0 | ||||
| Etrumadenant (AB928) | 2 | ||||
| Derenofylline (SLV320) | 0 | ||||
| BAY-545 | 0 | ||||
| Ciforadenant (CPI-444) | 2 | ||||
| Imaradenant (AZD4635) | 1 | ||||
| A2AR antagonist 1 | 2 | ||||
| SCH58261 | 7 | ||||
| Reversine | 16 | Aurora C,Aurora A,Aurora B | |||
| MIPS521 | 0 | ||||
| Proxyphylline | 0 | ||||
| ZM241385 | 9 |
| Description |
Anti-AA2AR / Adenosine A2aR (3F6-9G5) is a monoclonal antibody targeting A2A adenosine receptor. It may be an attractive target for research studies or treatments of insomnia, pain, depression, and Parkinson's disease. MW :146.66 KD.
|
References |
|---|
| Isotype | Human IgG1 |
|---|---|
| Source | CHO |
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.